Targeting Ferroptosis in Parkinson’s Disease: Mechanisms and Emerging Therapeutic Strategies
International Journal of Molecular Sciences · 04.12.2024 · 25 (23) · 13042
DOI: 10.3390/ijms252313042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.12.2024. Verfasst von Minghao Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdiscip…. Hauptthemen laut MEDLINE: Ferroptosis, Parkinson Disease, Lipid Peroxidation. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Jiangsu Funding Program for Excellent Postdoctoral Talent, Undergraduate Training Program for Innovation and Entrepreneurship of Soochow University.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra and the accumulation of α-synuclein in the brain. Ferroptosis, a recently identified form of regulated cell death, is critical in PD pathogenesis due to its association with iron deposition, overproduction of reactive oxygen species, iron-dependent lipid peroxidation and impaired lipid peroxidation clearance. This cell death mechanism is closely linked to several pathogenic processes in PD, including α-synuclein aggregation, oxidative stress, mitochondrial dysfunction, microglia-induced neuroinflammation, and neuromelanin accumulation. Given the significant role of ferroptosis in these mechanisms, there is increasing interest in targeting ferroptosis for PD treatment. Several drugs have shown potential in alleviating PD symptoms by inhibiting ferroptosis. This review aims to consolidate current knowledge on ferroptosis in PD and assess the therapeutic potential of anti-ferroptosis drugs, highlighting promising directions for future research and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiologic…
ORCID-Profile: Minghao Zhou, Jianxian Ge
Förderung
- the National Natural Science Foundation of China
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- Undergraduate Training Program for Innovation and Entrepreneurship of Soochow University
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- National Natural Science Foundation of China
- Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University
Zitieren
APA
Zhou, M., Xu, K., Ge, J., Luo, X., Wu, M., Wang, N., & Zeng, J. (2024). Targeting Ferroptosis in Parkinson’s Disease: Mechanisms and Emerging Therapeutic Strategies. International Journal of Molecular Sciences, 25(23), 13042. https://doi.org/10.3390/ijms252313042
Vancouver
Zhou M, Xu K, Ge J, Luo X, Wu M, Wang N, et al. Targeting Ferroptosis in Parkinson’s Disease: Mechanisms and Emerging Therapeutic Strategies. International Journal of Molecular Sciences. 2024;25(23):13042. doi:10.3390/ijms252313042
BibTeX
@article{Zhou2024,
author = {Zhou, Minghao and Xu, Keyang and Ge, Jianxian and Luo, Xingnian and Wu, Mengyao and Wang, Ning and Zeng, Jianfeng},
title = {Targeting Ferroptosis in Parkinson’s Disease: Mechanisms and Emerging Therapeutic Strategies},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {23},
pages = {13042},
doi = {10.3390/ijms252313042}
}
EUVIMED